Rucha Sane
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 12
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 12
- Hepatology top 10%
-
- PI3K/AKT/mTOR signaling in cancer 8
-
- Chronic Myeloid Leukemia Treatments 5
-
- Prostate Cancer Treatment and Research 4
-
- HIV/AIDS drug development and treatment 4
-
- Radiopharmaceutical Chemistry and Applications 3
-
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Pankaj B. DesaiDonna J. BuckleySrikanth C. NallaniArthur R. BuckleyNiresh HariparsadMitchell E. TaubLalitha PodilaBryan Goodwin
- Cited by
- PharmacologyOncologyHepatology
- Journals
- Drug Metabolism and Disposition (7 papers)Clinical and Translational Science (4 papers)The Journal of Clinical Pharmacology (4 papers)
- Partner nations
- United StatesSwitzerlandFrance
In The Last Decade
Rucha Sane
34 papers receiving 680 citations
Peers
Comparison fields: 5 of 81
- Pharmacology 284
- Oncology 305
- Hepatology 66
- Pediatrics, Perinatology and Child Health 151
- Virology 32
Countries citing papers authored by Rucha Sane
This map shows the geographic impact of Rucha Sane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rucha Sane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rucha Sane more than expected).
Fields of papers citing papers by Rucha Sane
This network shows the impact of papers produced by Rucha Sane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rucha Sane. The network helps show where Rucha Sane may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Rucha Sane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2023 | 9 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 4 | |
| 11 | 2022 | 7 | |
| 12 | 2021 | 4 | |
| 13 | 2021 | 16 | |
| 14 | 2015 | 23 | |
| 15 | 2014 | 8 | |
| 16 | 2014 | 22 | |
| 17 | 2011 | 57 | |
| 18 | 2005 | 31 | |
| 19 | 2004 | 160 | |
| 20 | 2002 | 106 |
About Rucha Sane
Rucha Sane is a scholar working on Pharmacology, Hematology and Oncology, having authored 36 papers that have together received 713 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (12 papers), Pharmacogenetics and Drug Metabolism (12 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Chronic Myeloid Leukemia Treatments (5 papers), Prostate Cancer Treatment and Research (4 papers), HIV/AIDS drug development and treatment (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Pharmacology (284 citations), Oncology (305 citations) and Hepatology (66 citations). Rucha Sane has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Pankaj B. Desai, Donna J. Buckley, Srikanth C. Nallani, Arthur R. Buckley, Niresh Hariparsad, Mitchell E. Taub, Lalitha Podila, Bryan Goodwin, Linda B. Moore and Kenta Yoshida. Their work appears in journals such as Drug Metabolism and Disposition, Clinical and Translational Science, The Journal of Clinical Pharmacology, Cancer Chemotherapy and Pharmacology and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.